Psoriasis and Psoriatic Arthritis Treatments Fueling Tremfya Market

toegevoegd een audio Health

2026-07-06 11:38:27 -

The rising burden of chronic inflammatory and autoimmune disorders has significantly increased demand for targeted biologic therapies. Among these, Tremfya (guselkumab) has emerged as a leading treatment option for moderate-to-severe plaque psoriasis and psoriatic arthritis. Strong Tremfya drug market growth, expanding guselkumab market applications, and increasing demand within...

0 Reacties 0 aandelen 21 Views 0 voorbeeld